We are live on ! Find out more
DU

Delphia (USA) Portfolio holdings

AUM $445K
1-Year Est. Return 28.82%
This Fund
S&P 500
This Quarter Est. Return
+10.45%
1 Year Est. Return
+28.82%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$86.6M
AUM Growth
-$935K
Cap. Flow
-$4.67M
Cap. Flow %
-5.39%
Top 10 Hldgs %
10.1%
Holding
387
New
106
Increased
68
Reduced
97
Closed
116

Top Sells

Rank Stock Value
1
UBER icon
Uber
UBER
+$806K
2
AVLR
Avalara, Inc.
AVLR
+$729K
3
DK icon
Delek US
DK
+$607K
4
ABT icon
Abbott
ABT
+$595K
5
DDOG icon
Datadog
DDOG
+$539K

Sector Composition

Rank Sector Weight
1 Technology 18.54%
2 Consumer Discretionary 17.01%
3 Energy 12.58%
4 Healthcare 10.41%
5 Industrials 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AME icon
276
Ametek
AME
$57.6B
-1,838
Closed -$208K
AMN icon
277
AMN Healthcare
AMN
$1.19B
-3,070
Closed -$325K
AMR icon
278
Alpha Metallurgical Resources
AMR
$1.93B
-2,470
Closed -$338K
AR icon
279
Antero Resources
AR
$10.7B
-8,809
Closed -$269K
ARLO icon
280
Arlo Technologies
ARLO
$1.68B
-21,359
Closed -$99K
ARVN icon
281
Arvinas
ARVN
$560M
-4,807
Closed -$214K
ASAN icon
282
Asana
ASAN
$2B
-10,815
Closed -$240K
ATNM icon
283
Actinium Pharmaceuticals
ATNM
$24.7M
-14,226
Closed -$105K
AXON
284
Axon Enterprise
AXON
$42.1B
-2,055
Closed -$238K
AYI icon
285
Acuity Brands
AYI
$10.7B
-1,541
Closed -$243K
BATRK icon
286
Atlanta Braves Holdings Series B
BATRK
$3.13B
-7,403
Closed -$204K
BBIO icon
287
BridgeBio Pharma
BBIO
$16.2B
-31,063
Closed -$309K
BCC icon
288
Boise Cascade
BCC
$2.94B
-3,653
Closed -$217K
BIIB icon
289
Biogen
BIIB
$30.5B
-1,270
Closed -$339K
BNY
290
Bank of New York Mellon
BNY
$108B
-8,572
Closed -$330K
BMY icon
291
Bristol-Myers Squibb
BMY
$131B
-3,595
Closed -$256K
BRY
292
DELISTED
Berry Corp
BRY
-12,937
Closed -$97K
BV icon
293
BrightView Holdings
BV
$1.02B
-20,152
Closed -$160K
BX icon
294
Blackstone
BX
$107B
-3,446
Closed -$288K
BXC icon
295
BlueLinx
BXC
$671M
-4,368
Closed -$271K
CAH icon
296
Cardinal Health
CAH
$55.7B
-4,404
Closed -$294K
CCK icon
297
Crown Holdings
CCK
$13.2B
-2,690
Closed -$218K
CCRN
298
DELISTED
Cross Country Healthcare
CCRN
-12,036
Closed -$341K
CEG icon
299
Constellation Energy
CEG
$93.2B
-3,196
Closed -$266K
CFFN icon
300
Capitol Federal Financial
CFFN
$1.11B
-10,681
Closed -$89K

Similar funds

Delphia (USA)'s Q4 2022 Portfolio in Review

As of Q4 2022, Delphia (USA) held 387 positions worth $86.6M, down 1.1% from $87.6M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Delphia (USA) withdrew a net $4.67M in Q4 2022, closing 116 positions and reducing 97 holdings. Its most notable exit was Uber, an estimated $806K position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Energy.

Against the trend, Delphia (USA) opened a new position in Lam Research worth $695K.

  • Delphia (USA)'s largest Q4 2022 buy was Lam Research: 16,540 shares worth $695K.
  • Delphia (USA) added most to Crescent Energy in Q4 2022, an estimated $615K increase.
  • Delphia (USA)'s biggest Q4 2022 reduction was Delek US, cutting an estimated $607K.
  • Delphia (USA) fully exited Uber in Q4 2022, selling an estimated $806K.
  • Delphia (USA)'s ten largest holdings make up 10% of its $86.6M portfolio in Q4 2022.
  • Delphia (USA) opened 106 new positions and closed 116 in Q4 2022.
  • Delphia (USA)'s portfolio value fell 1.1% quarter-over-quarter to $86.6M.

Based on Delphia (USA)'s 13F filing for Q4 2022, filed 14 Feb 2023.